VKTX
Viking Therapeutics Inc
35.60$
-3.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | -0.3% | -100.0% | – | – | – | |
| – | – | – | – | – | – | +6.5% | +6.9% | -1.7% | +0.3% | +18.5% | +24.6% | |
| – | – | – | – | – | – | – | -2,858.4% | – | – | – | – | |
| – | -68.7% | +29.2% | +52.7% | +38.6% | +23.7% | +35.5% | +40.9% | +20.6% | +17.6% | +59.3% | +239.4% | |
| – | +304.0% | -3.6% | +9.9% | +33.6% | +28.2% | +17.6% | -0.3% | +50.6% | +129.6% | +33.1% | -1.8% | |
| – | -48.9% | +15.4% | +37.7% | +37.2% | +24.0% | +31.6% | +30.5% | +26.4% | +43.3% | +49.7% | +160.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +62.0% | +99.5% | -4.0% | -71.2% | -74.0% | -27.4% | -83.0% | +227.8% | +49.2% | +6.8% | -40.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +56.2% | +98.4% | -4.9% | -246.4% | – | -149.8% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -61.4% | +952.2% | -644.5% | – | -1,550.9% | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.